about
Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192Characterization of human paraoxonase 1 variants suggest that His residues at 115 and 134 positions are not always needed for the lactonase/arylesterase activities of the enzyme.Expression and purification of biologically active recombinant human paraoxonase 1 from inclusion bodies of Escherichia coli.Expression, purification and immobilization of recombinant AiiA enzyme onto magnetic nanoparticles.Biocatalytic Synthesis of Allylic and Allenyl Sulfides through a Myoglobin-Catalyzed Doyle-Kirmse Reaction.Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1.Oxidized phospholipid content destabilizes the structure of reconstituted high density lipoprotein particles and changes their function.Gram-Scale Synthesis of Chiral Cyclopropane-Containing Drugs and Drug Precursors with Engineered Myoglobin Catalysts Featuring Complementary Stereoselectivity.Interplay between amino acid residues at positions 192 and 115 in modulating hydrolytic activities of human paraoxonase 1.Towards Understanding the Catalytic Mechanism of Human Paraoxonase 1: Experimental and In Silico Mutagenesis Studies.Improving storage stability of recombinant organophosphorus hydrolase.Improving Properties of Recombinant SsoPox by Site-Specific Pegylation.Differential interaction of peptides derived from C-terminal domain of human apolipoprotein E with platelet activating factor analogs.Stabilization studies on bacterially produced human paraoxonase 1 for improving its shelf life.Human paraoxonase 1 as a pharmacologic agent: limitations and perspectivesThe chemical nature of the polar functional group of oxidized acyl chain uniquely modifies the physicochemical properties of oxidized phospholipid-containing lipid particlesChemoselective Cyclopropanation over Carbene Y-H Insertion Catalyzed by an Engineered Carbene TransferaseRefolded Recombinant Human Paraoxonase 1 Variant Exhibits Prophylactic Activity Against Organophosphate PoisoningCellulase and xylanase synergism in industrial biotechnology
P50
Q35909827-8E870DCB-02D2-42D7-9F7C-D4391FF3BD0BQ37350343-DA055C20-C01C-4C48-B07A-272A17B16CECQ40908373-DA7EFA94-78D3-4AC7-99FB-7569A9A48FD2Q40931312-FA4243DF-90A5-45C2-83B9-590F464D6E1EQ42340889-1C39C5E2-34E0-4724-A41D-BB38952BF727Q44093660-FD685118-E163-4AD6-8198-2A45C43710B7Q45331904-1809A2ED-8301-48DB-BFCE-DD7ED993AFBEQ47099176-55F04D33-F89A-41B9-ACA7-C0A28F7752B5Q47988621-DE4DBFA9-A5B2-4F81-A1E2-84C07DE7BE4AQ51017237-4A2A4C30-71BE-4BE1-B730-52805085D0AEQ53574885-008C8311-E069-457E-8F50-5E99D8587619Q53815167-1AC28854-F25C-4638-9A75-19A8C8E72B84Q54273442-56356E09-8BE5-41EA-9C12-1FF98D62BF34Q54294286-146FF3E2-F47B-442E-B9AE-67B2C07F5E0CQ59101037-81F9B7A8-3E24-4DF7-B5DB-0A8B9657F370Q86791487-FBD658EC-853A-44A3-BEFA-0610F196B16AQ89112623-F88A5F5C-CBFF-45FF-AB12-DBE684E15C64Q89342313-CBCF0D4D-781A-442E-8AD0-3F333CFF3201Q90813574-0392CA05-E7F0-4D98-B466-CB45488A9D3E
P50
description
investigador
@es
researcher
@en
name
Priyanka Bajaj
@en
type
label
Priyanka Bajaj
@en
prefLabel
Priyanka Bajaj
@en
P31
P496
0000-0001-7813-3709